PSS Shareholder Suit Alleges Lax Accounting, Leading To Failed Fisher Deal
This article was originally published in The Gray Sheet
Executive Summary
A shareholder class action lawsuit against PSS World Medical alleges that lax accounting controls led to misleading disclosures and scuttled a planned merger with Fisher Scientific International.
You may also be interested in...
Fisher Extending Physician Market Reach Via PSS World Medical Purchase
Fisher Scientific's acquisition of medical products distributor PSS World Medical allows the company to triple the revenues of its nascent medical products unit Fisher HealthCare to roughly $2 bil. overnight, according to Fisher.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.